600079 人福醫藥
按盤價 
17.100 +1.150 (+7.210%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 6,367,372 | 2.28% | 24,524,741 | 22,337,719 | 20,548,930 | 20,680,111 | |
| 減：營業總成本 | 5,584,162 | 2.80% | 21,417,059 | 19,851,775 | 18,750,613 | 18,910,754 | |
| 其中:營業成本 | 3,412,876 | 2.33% | 13,290,992 | 12,615,138 | 11,764,845 | 11,999,654 | |
| 財務費用 | 80,454 | -33.93% | 304,519 | 236,944 | 623,308 | 916,149 | |
| 資產減值損失 | 987 | 295.71% | (61,407) | (88,312) | (55,124) | (59,357) | |
| 公允價值變動收益 | (6,536) | -107.21% | 136,855 | 43,417 | 7,885 | 16,403 | |
| 投資收益 | 16,871 | -84.20% | 206,785 | 835,557 | 306,009 | 324,105 | |
| 其中：對聯營企業和合營企業的投資收益 | 20,275 | -10.44% | 59,992 | 22,514 | 132,336 | 73,166 | |
| 營業利潤 | 822,514 | -18.67% | 3,447,174 | 3,516,028 | 2,249,040 | 2,091,872 | |
| 利潤總額 | 809,525 | -19.31% | 3,383,829 | 3,426,053 | 2,172,974 | 2,027,331 | |
| 減：所得稅費用 | 161,336 | 13.54% | 568,563 | 354,751 | 354,782 | 385,142 | |
| 淨利潤 | 648,189 | -24.73% | 2,815,266 | 3,071,302 | 1,818,193 | 1,642,189 | |
| 減：非控股權益 | 161,797 | -17.36% | 680,781 | 587,194 | 501,047 | 636,455 | |
| 股東淨利潤 | 486,392 | -26.89% | 2,134,485 | 2,484,109 | 1,317,146 | 1,005,733 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.300 | -26.83% | 1.320 | 1.540 | 0.830 | 0.730 | |
| 每股派息 (元) * | -- | -- | 0.460 | 0.160 | 0.150 | 0.100 | |
| 每股淨資產 (元) * | 10.723 | 11.21% | 10.441 | 9.210 | 7.929 | 6.891 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 带有强调事项段、持续经营重大不确定性段落、其他信息段落中包含其他信息未更正重大错报说明的无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 05/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
